During the past decade, Florida Hospital Cancer Institute conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 55 clinical trials were completed, i.e. on average, 119.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 21 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Hospital Cancer Institute" #1 sponsor was "SCRI Development Innovations, LLC" with 32 trials, followed by "Children's Oncology Group" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "Novartis Pharmaceuticals" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 74 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Hospital Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "Genentech, Inc." with 12 trials as a collaborator, "Novartis" with 7 trials as a collaborator, "Merck Sharp & Dohme LLC" with 6 trials as a collaborator and "Blood and Marrow Transplant Clinical Trials Network" with 4 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Florida Hospital Cancer Institute" are "Leukemia" (13 trials), "Ovarian Cancer" (11 trials), "Breast Cancer" (10 trials), "Lung Cancer" (8 trials) and "Lymphoma" (8 trials). Many other conditions were trialed in "Florida Hospital Cancer Institute" in a lesser frequency.

Most popular intervention types in "Florida Hospital Cancer Institute" are "Drug" (143 trials), "Biological" (30 trials), "Procedure" (16 trials), "Radiation" (15 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (16 trials), "radiation therapy" (13 trials), "filgrastim" (12 trials), "Bevacizumab" (10 trials) and "Paclitaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Florida Hospital Cancer Institute" are 128 trials for "All" genders, 30 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Florida Hospital Cancer Institute". undefined are not yet recruiting, 14 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 104 completed trials in Florida Hospital Cancer Institute, 1 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Hospital Cancer Institute, 22 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".